Addressing Unmet Needs & Physician’s Approach to Treatment Challenges in cHL

 

Addressing Unmet Needs & Physician’s Approach to Treatment Challenges in cHL
13:48

Anna Sureda

Safety Data of Brentuximab Vedotin in cHL and Management of Adverse Reactions: A Focus on Peripheral Neuropathy

  • 472 views
  • August 30, 2022
  • 1
11:27

Penn Medicine Abramson Cancer Center

EHA and ASCO 2022 Penn Medicine Updates on Targeted Therapies and Immunotherapies in Lymphoma

FEATURING Stefan Barta
  • 179 views
  • July 15, 2022
45:19

Nebraska Oncology Society

CD30 CAR T-Cells in Hodgkin Lymphoma

FEATURING Natalie Grover
  • 202 views
  • June 2, 2022
20:39

19th Annual International Ultmann Chicago Lymphoma Symposium

Post-Acute Outcomes After HL: An Epidemiologic Perspective

FEATURING Lindsay Morton
  • 55 views
  • July 8, 2022
  • 1
19:38

19th Annual International Ultmann Chicago Lymphoma Symposium

T-Cell Lymphomas: Impact of Classification on Treatment

FEATURING Neha Mehta-Shah
  • 455 views
  • July 8, 2022
  • 3
19:28

19th Annual International Ultmann Chicago Lymphoma Symposium

Impact of the Immune Landscape on Hodgkin Lymphoma Prognosis and Treatment

FEATURING Christian Steidl
  • 102 views
  • July 11, 2022
  • 1
15:36

19th Annual International Ultmann Chicago Lymphoma Symposium

Treatment of 1st Relapsed Classical Hodgkin Lymphoma

FEATURING Vaishalee Kenkre
  • 147 views
  • July 11, 2022
19:13

Siddhartha Ganguly

Updates in Hodgkin Lymphoma

  • 140 views
  • July 26, 2022
49

Siddhartha Ganguly

Lecture Summary - Updates in Hodgkin Lymphoma

  • 10 views
  • July 26, 2022
15:23

EHA 2022 Conference Coverage

Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Classical Hodgkin Lymphoma: 6-Year Analysis of ECHELON-1

FEATURING John Radford
  • 357 views
  • July 26, 2022
  • 1
01:52

EHA 2022 Conference Coverage

Lecture Summary - EHA 2022 Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Classical Hodgkin Lymphoma: 6-Year Analysis of ECHELON-1

FEATURING John Radford
  • 8 views
  • July 26, 2022
19:51

UChicago Medicine

Update on Immunotherapy Efforts in cHL and DLBCL

FEATURING Justin Kline
  • 211 views
  • August 19, 2022
  • 1
17:35

RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Lymphoma During Pregnancy

FEATURING Andrew Evens
  • 153 views
  • September 21, 2022
  • 1
16:18

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Sequencing Novel Agents in Frontline and Second-Line Treatment of Hodgkin Lymphoma

FEATURING Alison Moskowitz
  • 226 views
  • October 14, 2022
  • 1
10:35

SOHO 2022 Tenth Annual Meeting

SOHO 2022 Next Questions: Hodgkin Lymphoma

FEATURING Nancy Bartlett
  • 228 views
  • October 14, 2022
11:16

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Basis for Targeting the Microenvironment in Hodgkin Lymphoma

FEATURING Christian Steidl
  • 69 views
  • October 13, 2022